Excedrin Migraine (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-count tablets packaged in pouches, Distributed by Novartis Consumer Health, Inc., Parsippany, NJ, NDC 0067 203 702 Foreign packaging: b) Excedrin Migrana (Acetaminophen 250 mg, Aspirin 250 mg and 65 mg Caffeine) 2-ct pouches. The foreign packaging do not have NDC numbers
Published August 14, 2013 · Recall initiated: June 6, 2013
Summary
FDA records drug Class II recall D-844-2013, published August 14, 2013 and initiated June 6, 2013. Recalling firm: Novartis Consumer Health; Status: Terminated; Reported quantity: 10,624,000 pouches; Lot: Lot # a) 10116809, Exp 5/13 Foreign: Lot #s b) 10115644 Exp 5/13; 10118226 Exp 5/13; 10118227 Exp 6/13; 10118228 Exp 6/13; 10121956 Exp 8/13 and 10121957 Exp 8/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective container: products are packaged in pouches which may not have been fully sealed
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Novartis Consumer Health
- Distributor
- Nationwide, Puerto Rico, Brazil and Panama
- Lot
- Lot # a) 10116809, Exp 5/13 Foreign: Lot #s b) 10115644 Exp 5/13; 10118226 Exp 5/13; 10118227 Exp 6/13; 10118228 Exp 6/13; 10121956 Exp 8/13 and 10121957 Exp 8/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABenefiber fiber supplement stick packs, sugar free and taste free, packaged in the following configurations:March 5, 2014
- FDANeoCitran Extra Strength Cold & Flu (acetaminophen 650 mg, phenylephrine hydrochloride 10 mg, pheniramineJanuary 29, 2014
- FDANeoCitran Extra Strength (acetaminophen 650 mg, pseudoephedrine hydrochloride 60 mg, dextromethorphanJanuary 29, 2014
- FDATheraflu Severe Cold & Cough powder packets containing Daytime formula (acetaminophen 650 mg, dextromethorphanJanuary 29, 2014
- FDAExcedrin Extra Strength (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-ct tablets inAugust 14, 2013
- FDANo Doz, Max Strength (200 mg caffeine) caplets, 2-count caplets per pouch, Distributed by Novartis ConsumerAugust 14, 2013
Questions about this recall
Was Excedrin Migraine (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-count tablets packaged in pouches, Distributed by Novartis Consumer Health, Inc., Parsippany, NJ, NDC 0067 203 702 Foreign packaging: b) Excedrin Migrana (Acetaminophen 250 mg, Aspirin 250 mg and 65 mg Caffeine) 2-ct pouches. The foreign packaging do not have NDC numbers recalled?
Yes. FDA published recall D-844-2013 on August 14, 2013. Reported hazard: Defective container: products are packaged in pouches which may not have been fully sealed
What should I do if I have this product?
Voluntary: Firm initiated · Letter